jackie.vuistiner

Case report: Youngest patient ever treated with denovoSkin – a neonatal case

The paper published in Burns Open has presented the case of a four day-old neonate suffering from life threatening burns, involving 40% total body surface area burn. The patient received 260 cm2 of denovoSkin, covering 20% TBSA, as part of a clinical trial sub-study in Italy. The management of such cases represents an unprecedented challenge. […]

Case report: Youngest patient ever treated with denovoSkin – a neonatal case Read More »

Fierce Biotech interview

The leading industry media Fierce Biotech reported on the news that CUTISS sent human skin cells into space, for advanced R&D testing on the International Space Station. Our Chief Innovation Officer Vincent Ronfard explained in his interview the reasons for conducting such experiments and what we hope to achieve. The initial round of experiments will

Fierce Biotech interview Read More »

Advanced testing of human skin cells on the International Space Station to push the boundaries of innovation in regenerative medicine

As part of the company’s R&D in regenerative medicine, CUTISS will observe the effects of space on skin cells and tissue culture. Research implications towards human safety in space travel and new discoveries in regenerative medicine and tissue engineering on Earth. Four-week mission conducted in collaboration with SpacePharma which specializes in space-based experiments and micro-lab

Advanced testing of human skin cells on the International Space Station to push the boundaries of innovation in regenerative medicine Read More »

BioVoice CUTISS interview with Dr. Daniela Marino

Following our presence at Arab Health 2023 we had the opportunity to speak with BioVoice, the top Indian bioscience news magazine. In the interview, our CEO Daniela Marino shared the progress that CUTISS has been making in bioengineering the personalized skin graft denovoSkin, the commercial plans around skin pigmentation, and the exciting innovations in regenerative

BioVoice CUTISS interview with Dr. Daniela Marino Read More »

Gulf Today interview

CUTISS exhibited at the Arab Health 2023 expo in Dubai and had the opportunity to speak with Gulf Today. Our CEO Daniela Marino talked about how she got into the field, what made her decide to start a company, and the promising innovations that CUTISS is developing in skin tissue engineering, skin pigmentation, and regenerative

Gulf Today interview Read More »

CUTISS to participate in Jefferies London Healthcare Conference 2022

Switzerland, 7 November 2022 – CUTISS AG, a Swiss clinical-stage life sciences company focused on skin regenerative medicine and tissue engineering, has announced that the company is invited to the upcoming Jefferies London Healthcare Conference, taking place November 15 – 17, 2022. Dr Daniela Marino, Chief Executive Officer and co-founder at CUTISS, will attend the conference

CUTISS to participate in Jefferies London Healthcare Conference 2022 Read More »

Swiss RTS television reportage on innovation and denovoCast

More than a year since CUTISS announced the world’s first machine to bioengineer human skin, the news continues to generate interest and excitement. As part of their program focused on Swiss innovation, the broadcaster RTS (Neuchatel) visited CUTISS and CSEM who helped develop the denovoCast machine, to find out how automation can scale-up the production

Swiss RTS television reportage on innovation and denovoCast Read More »

ceo magazine interview

The October issue of PwC Switzerland’s ceo magazine is dedicated to the topic of courage. The courage to make decisions, and the courage to set out on the path of entrepreneurship. Our CEO Daniela was interviewed for this edition where she talked about setting up CUTISS, her ambitions, calculated risks, and outcomes for patients suffering from severe burns.

ceo magazine interview Read More »

Tribune de Côte d’Azur reports on CUTISS Innovation

The Tribune de Côte d’Azur covered the first ‘Impact Awards’ 2022, a jury-led competition organized by Team Côte d’Azur that recognizes leading companies of the local economic ecosystem. CUTISS Innovation, our French subsidiary, was honored to win the ‘Innovation’ trophy for continued innovation and research into regenerative medicine and skin pigmentation. Our director Cécile Cousin was

Tribune de Côte d’Azur reports on CUTISS Innovation Read More »

Scroll to Top

Newsletter

Would you like to contact us as a journalist?

©WyssZurich

This website uses cookies to ensure you get the best experience on our website.